Rare diseases
Investigational molecules
Locations
Back to Germany42 clinical trials in Villingen-Schwenningen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancers, including colon cancer, lymphoma, and multiple myeloma. Studies evaluate new therapeutic approaches and drug combinations to improve patient outcomes.
Research includes evaluation of targeted therapies and immunotherapy approaches for better treatment efficacy.
Extensive research into kidney diseases, particularly IgA Nephropathy and related conditions. Multiple trials are investigating novel therapeutic agents to preserve kidney function and reduce disease progression.
Studies focus on innovative treatments and their impact on kidney function preservation.
Research centered on treating metabolic conditions, including Type 2 Diabetes and obesity. Trials evaluate new medications' effectiveness in managing these chronic conditions.
Studies aim to improve patient outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
